The eyes may be windows to the soul, but the nose is a gateway to the mucosal immune system. Drug companies are now developing vaccines to take advantage of that gateway. Courtesy of Aviron MISTING UP: Aviron's nasal flu vaccine, which has recently completed Phase III trials, targets the mucosal system and protects against both flu and ear infection. "If you can stimulate the mucosal immune system--that's the majority of the immune system," explains Larry G. Stambaugh, president and CEO of M
The eyes may be windows to the soul, but the nose is a gateway to the mucosal immune system. Drug companies are now developing vaccines to take advantage of that gateway.
| Courtesy of Aviron |
 MISTING UP: Aviron's nasal flu vaccine, which has recently completed Phase III trials, targets the mucosal system and protects against both flu and ear infection. |
Recombinant cholera toxin subunit B (rCTB) provides the heart of the ...
In mammals, intracellular clocks begin to tick within days of fertilization.
View this Issue
Learn how mastering the ins and outs of PCR can accelerate workflows and improve data.
Molecular detection technologies help scientists rapidly and reliably find and address ever-evolving pathogens with optimal accuracy and sensitivity.
Discover the key features to consider when selecting a new refrigerator or freezer
In this webinar, Kevin J. Tracey and Lawrence Steinman will discuss how researchers study the immunology of the brain and its roles in health and disease.
Zymo Research Corp., a leader in biotechnology and microbiome research solutions, proudly announces the launch of its new Quick-16S™ Full-Length Library Prep Kit.
Industry Recognizes BIOVECTRA’s Excellence in Microbial Fermentation, Recombinant Protein Production, and Aseptic Fill-Finish Capabilities
On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).
Slow temperature recovery can threaten the integrity of your work. That’s Stirling Ultracold designed the VAULT100™ to operate at setpoints down to -100°C, so your samples may never be exposed to temperatures above -70°C during a typical door opening.
